TQB3702 Tablets

TQB3702 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB3702 Tablets, covering 2025-03-05 to 2025-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 2]